Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
2.550
-0.160 (-5.90%)
At close: Jun 23, 2026, 4:00 PM EDT
2.550
0.00 (0.01%)
After-hours: Jun 23, 2026, 5:05 PM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $5.47 million as of June 23, 2026. Its market cap has increased by 9.61% in one year.
Market Cap
5.47M
Enterprise Value
882.13K
1-Year Change
9.61%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.33M to $5.47M, a decrease of -79.24%. That is a compound annual growth rate of -18.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 5.47M | -6.77% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.55M | 131.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 6.27M |
| BioAtla | 6.06M |
| Soligenix | 5.92M |
| Cardio Diagnostics Holdings | 5.86M |
| Processa Pharmaceuticals | 5.83M |
| Aptevo Therapeutics | 5.82M |
| XTL Biopharmaceuticals | 5.75M |
| Evogene | 5.60M |